Apollo Stack vs Wolverine Stack
A side-by-side research comparison of Apollo Stack and Wolverine Stack across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Apollo Stack | Wolverine Stack |
|---|---|---|
| Full name | Apollo (Semaglutide + 5-Amino-1MQ + MOTS-c + Tesamorelin) | Wolverine (BPC-157 + TB-500 Combination) |
| Category | Popular Stacks | Popular Stacks |
| Status | Research stack | Research stack |
| Mechanism | Semaglutide activates GLP-1 receptors for appetite/glucose control. 5-Amino-1MQ inhibits NNMT to boost NAD+ and cellular energy. MOTS-c activates AMPK like exercise. Tesamorelin specifically targets visceral fat through GH-mediated lipolysis. | BPC-157 upregulates VEGF and promotes localized angiogenesis at injury sites. TB-500 upregulates actin expression, promoting cell migration and reducing inflammation systemically. The combination addresses both local and systemic repair pathways. |
| Molecular weight | Multiple compounds | BPC-157: 1419 Da + TB-500: 4921 Da |
| Half-life | Semaglutide: ~7 days, 5A1MQ: ~6h, MOTS-c: ~4h, Tesamorelin: ~30min | BPC-157: ~4h, TB-500: ~6h |
| Bioavailability | Variable by component | ~95% subcutaneous for both |
| Typical dose | Sema 0.25-2.4mg/wk + 5A1MQ 100mg 2x/day + MOTS-c 10mg 3x/wk + Tesa 2mg/day | BPC-157 500mcg + TB-500 2.5mg |
| Frequency | Variable by component | BPC-157 daily · TB-500 2x/week |
| Route | SC injection + Oral | Subcutaneous injection |
Apollo Stack reported benefits
- Dramatic fat loss
- Visceral fat reduction
- Metabolic rate increase
- Appetite control
- Improved insulin sensitivity
- Cellular energy boost
Wolverine Stack reported benefits
- Accelerated injury recovery
- Tendon and ligament repair
- Reduced systemic inflammation
- Improved flexibility
- Gut healing
- Post-surgical recovery
Related comparisons
Research and educational reference only. Not medical advice.